> top > docs > PMC:7079563 > spans > 23923-24249 > annotations

PMC:7079563 / 23923-24249 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
708 316-325 Species denotes 2019-nCoV Tax:2697049
723 298-307 Disease denotes infection MESH:D007239

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T81 171-173 Disease denotes GS http://purl.obolibrary.org/obo/MONDO_0005773
T82 298-307 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T174 282-287 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T64 6-21 Chemical denotes antiviral drugs http://purl.obolibrary.org/obo/CHEBI_36044
T65 6-15 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T66 16-21 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T67 28-31 Chemical denotes FAD http://purl.obolibrary.org/obo/CHEBI_16238|http://purl.obolibrary.org/obo/CHEBI_57692|http://purl.obolibrary.org/obo/CHEBI_73627
T70 41-46 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T71 57-66 Chemical denotes ribavirin http://purl.obolibrary.org/obo/CHEBI_63580
T72 68-79 Chemical denotes penciclovir http://purl.obolibrary.org/obo/CHEBI_7956
T73 104-115 Chemical denotes chloroquine http://purl.obolibrary.org/obo/CHEBI_3638
T74 144-159 Chemical denotes antiviral drugs http://purl.obolibrary.org/obo/CHEBI_36044
T75 144-153 Chemical denotes antiviral http://purl.obolibrary.org/obo/CHEBI_22587
T76 154-159 Chemical denotes drugs http://purl.obolibrary.org/obo/CHEBI_23888
T77 171-178 Chemical denotes GS-5734 http://purl.obolibrary.org/obo/CHEBI_145994
T78 171-173 Chemical denotes GS http://purl.obolibrary.org/obo/CHEBI_73516
T79 193-198 Chemical denotes T-705 http://purl.obolibrary.org/obo/CHEBI_134722

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T183 0-326 Sentence denotes Other antiviral drugs, like FAD-approved drugs including ribavirin, penciclovir, nitrazine, nalfamusta, chloroquine, and the two broad-spectrum antiviral drugs redexivir (GS-5734) and favivir (T-705), are being evaluated by measuring the effects of these compounds on cytotoxicity, virus yield and infection rate of 2019-nCoV.